| Dr Shewangizaw Worku, MD, PHD | |
|
9055 Springbrook Dr Nw, Coon Rapids, MN 55433-5841 | |
| (763) 780-9155 | |
| Not Available |
| Full Name | Dr Shewangizaw Worku |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 36 Years |
| Location | 9055 Springbrook Dr Nw, Coon Rapids, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922041383 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 2004036409 (Missouri) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital | Coon rapids, MN | Hospital |
| Abbott Northwestern Hospital | Minneapolis, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allina Health System | 4587573613 | 3071 |
News Archive
Patients with cystic fibrosis typically take large numbers of medicines and are managed by healthcare professionals in both primary and secondary care. Most of patients' regular medication is prescribed by general practitioners, whereas complex and new treatments are initiated and provided through hospital outpatient clinics.
Even though scientists already knew at least as far as animals are concerned, that reducing the calorie intake was linked to longevity, they never really knew why.
CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for Ebola. The investigational drug candidate, designed to inhibit a major cellular adhesion receptor (CD29) that is fundamental for progression of aggressive and resistant cancer tumors, was granted orphan drug designation by the U.S. FDA earlier this year in the treatment of glioblastoma.
Being in regular contact with healthcare providers because of a chronic illness such as diabetes or heart disease doesn't necessarily mean a person is more likely to have a cancer detected early, according to a study led by Duke University Comprehensive Cancer Center researchers.
ClearCount Medical Solutions and Medline Industries, Inc. today announced that its newest customer, the VA Pittsburgh Healthcare system will help prevent retained surgical sponge incidents with the use of the SmartSponge System®. The SmartSponge System is part of ClearCount's radio-frequency identification -based platform that uniquely identifies each sponge so that they can be easily counted and detected.
› Verified 9 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
Patients with cystic fibrosis typically take large numbers of medicines and are managed by healthcare professionals in both primary and secondary care. Most of patients' regular medication is prescribed by general practitioners, whereas complex and new treatments are initiated and provided through hospital outpatient clinics.
Even though scientists already knew at least as far as animals are concerned, that reducing the calorie intake was linked to longevity, they never really knew why.
CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for Ebola. The investigational drug candidate, designed to inhibit a major cellular adhesion receptor (CD29) that is fundamental for progression of aggressive and resistant cancer tumors, was granted orphan drug designation by the U.S. FDA earlier this year in the treatment of glioblastoma.
Being in regular contact with healthcare providers because of a chronic illness such as diabetes or heart disease doesn't necessarily mean a person is more likely to have a cancer detected early, according to a study led by Duke University Comprehensive Cancer Center researchers.
ClearCount Medical Solutions and Medline Industries, Inc. today announced that its newest customer, the VA Pittsburgh Healthcare system will help prevent retained surgical sponge incidents with the use of the SmartSponge System®. The SmartSponge System is part of ClearCount's radio-frequency identification -based platform that uniquely identifies each sponge so that they can be easily counted and detected.
› Verified 9 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457657249 PECOS PAC ID: 4587573613 Enrollment ID: O20221213001713 |
News Archive
Patients with cystic fibrosis typically take large numbers of medicines and are managed by healthcare professionals in both primary and secondary care. Most of patients' regular medication is prescribed by general practitioners, whereas complex and new treatments are initiated and provided through hospital outpatient clinics.
Even though scientists already knew at least as far as animals are concerned, that reducing the calorie intake was linked to longevity, they never really knew why.
CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for Ebola. The investigational drug candidate, designed to inhibit a major cellular adhesion receptor (CD29) that is fundamental for progression of aggressive and resistant cancer tumors, was granted orphan drug designation by the U.S. FDA earlier this year in the treatment of glioblastoma.
Being in regular contact with healthcare providers because of a chronic illness such as diabetes or heart disease doesn't necessarily mean a person is more likely to have a cancer detected early, according to a study led by Duke University Comprehensive Cancer Center researchers.
ClearCount Medical Solutions and Medline Industries, Inc. today announced that its newest customer, the VA Pittsburgh Healthcare system will help prevent retained surgical sponge incidents with the use of the SmartSponge System®. The SmartSponge System is part of ClearCount's radio-frequency identification -based platform that uniquely identifies each sponge so that they can be easily counted and detected.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Shewangizaw Worku, MD, PHD 2925 Chicago Ave, Minneapolis, MN 55407-1321 Ph: (612) 262-5000 | Dr Shewangizaw Worku, MD, PHD 9055 Springbrook Dr Nw, Coon Rapids, MN 55433-5841 Ph: (763) 780-9155 |
News Archive
Patients with cystic fibrosis typically take large numbers of medicines and are managed by healthcare professionals in both primary and secondary care. Most of patients' regular medication is prescribed by general practitioners, whereas complex and new treatments are initiated and provided through hospital outpatient clinics.
Even though scientists already knew at least as far as animals are concerned, that reducing the calorie intake was linked to longevity, they never really knew why.
CMC Biologics and OncoSynergy have entered into an agreement for process development and GMP manufacture of OS2966 – a novel potential treatment for Ebola. The investigational drug candidate, designed to inhibit a major cellular adhesion receptor (CD29) that is fundamental for progression of aggressive and resistant cancer tumors, was granted orphan drug designation by the U.S. FDA earlier this year in the treatment of glioblastoma.
Being in regular contact with healthcare providers because of a chronic illness such as diabetes or heart disease doesn't necessarily mean a person is more likely to have a cancer detected early, according to a study led by Duke University Comprehensive Cancer Center researchers.
ClearCount Medical Solutions and Medline Industries, Inc. today announced that its newest customer, the VA Pittsburgh Healthcare system will help prevent retained surgical sponge incidents with the use of the SmartSponge System®. The SmartSponge System is part of ClearCount's radio-frequency identification -based platform that uniquely identifies each sponge so that they can be easily counted and detected.
› Verified 9 days ago
Dr. Jaya Bhattarai, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4050 Coon Rapids Blvd Nw, Coon Rapids, MN 55433 Phone: 763-236-6000 | |
Zongyu J Chen, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9145 Springbrook Dr, #200, Coon Rapids, MN 55433 Phone: 612-871-1145 Fax: 612-870-5491 | |
Amber Galarowicz, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 4050 Coon Rapids Blvd Nw, Coon Rapids, MN 55433 Phone: 763-236-6000 | |
Evan L Domeyer, DO Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3960 Coon Rapids Blvd Nw, 100, Coon Rapids, MN 55433 Phone: 763-236-9400 Fax: 763-236-9423 | |
Natalia Yazigi, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 | |
Linda Benjamin Soucie, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3960 Coon Rapids Blvd Nw, 100, Coon Rapids, MN 55433 Phone: 763-236-9400 Fax: 763-236-9423 | |
Wendoly R Slattery, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 9055 Springbrook Dr Nw, Coon Rapids, MN 55433 Phone: 763-780-9155 |